Attending this event?
Back To Schedule
Tuesday, September 20 • 2:15pm - 3:00pm
Panel: Transitioning to Decentralized Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

avatar for Amir Lahav Sc.D

Amir Lahav Sc.D

Digital Healthcare Innovation, Head of Strategic R&D, Mitsubishi Tanabe Pharma America
Amir is a Digital Health Advisor and a leading innovator at the forefront of tech innovation and clinical research. Amir has nearly two decades of experience in the biotech and healthcare industries. He currently sits on the Advisory Board of leading HealthTech startups (Curbase... Read More →

avatar for Antoniu Fantana,  PhD

Antoniu Fantana, PhD

Sr. Director, Lead Emerging Technology Strategy - Clinical Design, Delivery and Analytics, Eli Lilly and Company
Tony Fantana is passionate about creatively solving high unmet medical need problems by assembling, leading, and developing great teams. He currently leads the emerging technology strategy in clinical development at Eli Lilly & Company. There, he is responsible for executing pilots... Read More →
avatar for Joel Morse

Joel Morse

CEO and Co-Founder, Curavit Clinical Research
Joel Morse is CEO and co-founder of Curavit Clinical Research. Founded in late 2019, Curavit is a virtual CRO focused on designing and executing Decentralized Clinical Trials (DCTs). Prior to founding Curavit, Joel was co-founder and CEO of C3i, a global provider of clinical trial... Read More →

Tuesday September 20, 2022 2:15pm - 3:00pm EDT